Clinical Trial Update: Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating risperidone for bipolar disorder in children and adolescents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED